About: Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2000 (uk) article scientifique publié en juillet 2000 (fr) im Juli 2000 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57009969-B92C604E-E37B-4BE7-9AAA-4932464BECFD
publication date	2000-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57009969-0A190958-6F65-4964-A469-24F5E3F593D6
language of work or name	English
author name string	wds:Q57009969-07C9B2C9-3892-4D48-B2F2-6A8CA854D74C wds:Q57009969-0D7C0D6A-6098-40C9-B005-072DA6FEE5B8 wds:Q57009969-111C81E6-F537-4C55-BE72-BEF67F17F5E6 wds:Q57009969-3EE21724-7A62-484A-8E72-7547A54091D0 wds:Q57009969-3FBDFFF2-1762-44B5-99F3-B451173B82FF wds:Q57009969-574652CF-A1B0-4E36-AE65-0006C957477A wds:Q57009969-864DBEBE-ACDA-4E30-BDC0-F01759923061 wds:Q57009969-90837278-F861-4AD1-A446-4FFAF755074C wds:Q57009969-9A3E4AAB-CB5A-4460-A11B-42283C1E5A98 wds:Q57009969-AA216650-5630-4BDA-829C-3A0DEEDF6289 wds:Q57009969-BFBEAB61-78B3-4FFE-A8BB-92060DCC717E
author name string	F Gherlinzoni P L Zinzani S A Pileri S Ascani S Tura M Magagnoli R Simoni G Baliva G F Orcioni G Modugno M Bendandi
rdfs:label	Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients (en) Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients (nl)
skos:prefLabel	Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients (en) Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients (nl)
name	Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients (en) Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients (nl)
title	wds:Q57009969-49233353-D09C-4BC6-8244-9D8B686AC21B
title	Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients (en)
page(s)	wds:Q57009969-A903D3A8-CECB-481D-98FB-58E1D0F4DAB8
page(s)	2603-6
instance of	wds:Q57009969-0A4FB2C6-17FA-4389-AC80-46D13143B64F
instance of	scholarly article
main subject	wds:Q57009969-F85C1EF3-74A8-43B9-B2B2-E5C050A2398E
main subject	Patients
PubMed ID	wds:Q57009969-6D35C95B-8E19-4022-8B65-CF2CD7ACF2ED
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10893292
PubMed ID	10893292
published in	wds:Q57009969-638C7A64-20BC-4782-9F9D-0A4BD506C38C
published in	Journal of Clinical Oncology
issue	wds:Q57009969-82F64486-BC8E-4548-BB6A-881FFDDD6352
volume	wds:Q57009969-B72545C5-7371-4D32-83E1-C014B65193FD
issue	13
volume	18
DOI	wds:Q57009969-388F2EB6-768B-4F7D-8F7D-728462EE556C
DOI	http://dx.doi.org/10.1200/JCO.2000.18.13.2603
DOI	10.1200/JCO.2000.18.13.2603
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57009969
is cites work of	Current and emerging treatment strategies for cutaneous T-cell lymphoma The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study Peripheral T-cell lymphomas: diagnosis and management Treatment of refractory T-cell malignancies using gemcitabine Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium Follow-up of patients with mycosis fungoides after interferon α2b treatment failure Treatment of patients with advanced mycosis fungoides and Sézary syndrome with alemtuzumab Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350. Treatment of mycosis fungoides: overview Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome) Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma Mechanisms of apoptosis induction by nucleoside analogs. Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC). miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplan Gemcitabine and vinorelbine treatment in cutaneous T-cell lymphoma in four patients. Peripheral T-cell lymphoma Review of the treatment of mycosis fungoides and Sézary syndrome: A stage-based approach Model-based drug development: the road to quantitative pharmacology Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks? Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma MDM2 inhibitor nutlin-3a induces apoptosis and senescence in cutaneous T-cell lymphoma: role of p53. Cutaneous T-cell lymphomas: a review of new discoveries and treatments Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma T-cell lymphomas, a challenging disease: types, treatments, and future. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software